Introduction

Superdrol 50Methyldrostanolone2

Factory 1

musclepic 4

Products Description

1. Product Positioning and Form Classification

From a commercial and product form perspective, products containing methyldrostanolone can be broadly divided into three categories: oral tablets or capsules (historically the most common form of Superdrol), raw powder (for research or formulation), and a small number of "oil injections" available on the black market or in some online stores (e.g., multi-dose vials labeled 50 mg/ml and 10 ml). Each category has distinct uses, risks, and regulatory status. Oral methyldrostanolone derivatives are known for their potent hepatotoxicity, and the presence of an oil formulation does not necessarily reduce risk; rather, it may pose additional risks if improper preparation and quality control are inadequate. Examples of 50 mg/ml and 10 ml oil formulations available on the market can be found on individual product pages, but they are not mainstream or widely recognized regulated formulations in the medical community.

2. Chemical and Physicochemical Properties (Basic Reference)

Methyldrostanolone has a molecular formula of C21H34O2 and belongs to a class of dihydrotestosterone (DHT) derivatives. Its molecular structure features a methyl modification at the 17α-position and a methyl substitution at the 2α-position, which enhances its oral stability and metabolic resistance. Public databases and chemical data provide the following information on the compound's physicochemical properties: molecular formula, molecular weight, melting point (data indicate a high melting point), density, and solubility in common organic solvents (such as ethanol, DMSO, and DMF). Overall, methyldrostanolone is a crystalline solid that is readily soluble in polar organic solvents and has very low water solubility. It is suitable for use as a precursor for injectable or oral formulations in oil-based or organic solvents. These physical properties can be verified in authoritative chemical databases and chemical data repositories.

3. Appearance, Color, and Formulation Presentation

High-purity methyldrostanolone raw material is typically a white to off-white crystalline powder. Products packaged as oils typically appear as clear or pale yellow oil solutions (depending on the carrier oil, added flavorings or preservatives, and solubility and stability). Sometimes, depending on the solvent or excipient, the color can range from light yellow to amber. The presence of dark precipitate, turbidity, or an unusual odor often indicates poor product stability, adulteration, or improper storage, and its quality should be highly questioned. Some vendors often display the 50 mg/ml (10 ml bottle) formulation in small glass bottles in product images and descriptions, but this does not necessarily equate to a prescription injectable formulation certified by a formal pharmacopoeia or regulatory body.

4. Advantages and Selling Points (Commercial Promotion)

Manufacturers or sales pages often describe Superdrol's "advantages" as: potent anabolic effects, rapid stimulation of muscle protein synthesis, increased strength and stamina, and achieved "dry" muscle mass (less edema). On some product pages, the high-concentration 50 mg/ml, 10 ml multi-dose package is promoted as an "efficient, convenient, and cost-effective" option. It's important to note that these so-called "advantages" are largely based on non-medical marketing or user testimonials, lacking comprehensive safety and long-term efficacy data from authoritative clinical trials. In terms of pharmacological properties, these 17α-methylated DHT derivatives often exhibit significant anabolic effects, but their potential toxicity (particularly hepatic and cardiovascular) presents a key challenge alongside these "advantages."

5. Major Risks and Adverse Reactions (Medical Evidence)

Numerous clinical cases and literature reports have linked methyldrostanolone to severe hepatotoxicity, including reports of acute cholestatic liver injury, markedly elevated liver enzymes, and even liver failure. Academic reports, case studies, and reviews have consistently noted that these 17α-alkylated anabolic steroids have historically been associated with severe liver injury, with some cases requiring hospitalization or leading to a dramatic deterioration of organ function. Furthermore, users may experience adverse reactions such as dyslipidemia (lowered HDL cholesterol, elevated LDL cholesterol), elevated blood pressure, increased cardiovascular risk, endocrine suppression (inhibition of natural testosterone production), increased sebum secretion/acne, and masculinization (particularly in women). In summary, the risks are not low-probability events, but rather key concerns frequently identified in the literature and clinical observations.

6. Formulation and Quality Control (Non-Process Description)

Any pharmaceutical or quasi-pharmaceutical-grade injectable solution should undergo rigorous quality control, including but not limited to raw material identification (NMR, MS, IR), content determination (HPLC or GC), impurity profiling, sterility and endotoxin testing, residual solvent testing, and stability testing. Over-the-counter/black market oils available commercially or online often lack such rigorous Certificates of Analysis (COA) or third-party laboratory validation, making it difficult to guarantee their labeled content, purity, impurity profile, and microbiological safety. Requiring a formal test report for any oil product claiming to contain methyldrostanolone is essential to assess its reliability.

7. Legal and Regulatory Issues

In many countries/regions, methyldrostanolone or its derivatives are listed as controlled substances or regulated as stimulants/controlled drugs, and their production, sale, and use are subject to strict legal restrictions. Historically, this substance was marketed as a "designer supplement." However, with increasing safety concerns and regulatory intervention, many countries have placed it on banned or controlled lists, posing legal risks for cross-border purchase and transportation. Purchasing or possessing unauthorized steroid preparations may result in criminal or civil liability in some jurisdictions.

8. Storage, Expiration Date, and Packaging Precautions

Regular pharmaceutical-grade oils should be packaged in dark glass bottles or certified plastic containers with a seal stopper and aluminum cap. The packaging must clearly indicate the active ingredient, batch number, production date, expiration date, storage conditions, and a reference to the test report for the production batch. Ideal storage conditions are a cool, dry environment away from direct sunlight; avoid high temperatures and freeze-thaw cycles. Untested or unlabeled products should not be considered qualified pharmaceuticals.

9. User Risk Warning (Serious Disclaimer)

The content herein provides an introduction to the product and its scientific properties and provides a literature review. It is not intended as a prescribing recommendation or usage guide. Methyldrostanolone (Superdrol) and similar 17α-methylated anabolic steroids have been repeatedly reported to cause severe liver damage and other systemic adverse reactions. Anyone considering handling, purchasing, or using these substances should consult a qualified medical professional and understand the legal implications in their jurisdiction. If you suspect you or others may experience health problems after using these substances, you should seek medical attention immediately and disclose the substance you used to your healthcare provider for prompt treatment.

10. Conclusion and Recommendations (not usage recommendations)

Superdrol, presented as a 50 mg/ml, 10 ml oil solution, is one of the most controversial product forms on the market. From a chemical and pharmacological perspective, methyldrostanolone has potent anabolic potential. However, from a public health and regulatory perspective, its significant hepatotoxicity, cardiovascular and endocrine adverse effects, and uncertainties regarding legal and quality control make it a significantly higher risk than typical over-the-counter supplements. For scientific research institutions or compliant medical research, any operation involving this substance should be carried out under compliance supervision and ethical approval; for the general public, the safest practice is to avoid over-the-counter use, seek medical alternatives and follow legal channels when health needs arise.